Company · CIK 0001638287
MetaVia Inc.
MTVASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$1.41+$0.07 (+5.22%)
MTVA · Last trade
- Prev close
- $1.34
- Range (29d)
- $1.34 – $1.75
On the record
Recent filings
- 8-KMTVACurrent report0001104659-26-106156 · 235.4 KBSEC(opens sec.gov)
- 10-QMTVAQuarterly update0001104659-26-092051 · 6.5 MBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-091981 · 6.6 MBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-082116 · 323.7 KBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-080316 · 259.7 KBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-071358 · 265.6 KBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-071211 · 259.7 KBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-066631 · 244.2 KBSEC(opens sec.gov)
- 8-KMTVACurrent report0001104659-26-063059 · 247.9 KBSEC(opens sec.gov)
- 10-QMTVAQuarterly update0001104659-26-061166 · 5.3 MBSEC(opens sec.gov)
Insiders
- Bakshi AkashDirector, SVP and COO
- Bisgaier Charles PhDDirector, Chief Scientific Off. & Chair, 10% Owner
- DONG-A ST CO., LTD10% Owner
- E&Investment, Inc.10% Owner
- Glickman Mark ADirector
- Golden Lee ScottChief Medical Officer
- GOLDMAN SACHS & CO. LLC10% Owner
- GOLDMAN SACHS GROUP INC10% Owner
- GROVES JASON LDirector
- Gullans Steven R. Ph.D.Director
Tickers
Addresses
business
545 CONCORD AVENUE SUITE 210
CAMBRIDGE, MA, 02138
mailing
545 CONCORD AVENUE SUITE 210
CAMBRIDGE, MA, 02138
Former names
- NeuroBo Pharmaceuticals, Inc.2024-11-18
- Gemphire Therapeutics Inc.2019-12-31
Same industry